A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Condition: Type 2 Diabetes Mellitus · Sponsor: AstraZeneca
About this study
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)
This description comes directly from the study's public registry record.
Talk to the study team
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
Locations (132)
| Research Site | Little Rock, Arkansas, United States | Not Yet Recruiting |
| Research Site | Sacramento, California, United States | Not Yet Recruiting |
| Research Site | Aurora, Colorado, United States | Not Yet Recruiting |
| Research Site | DeLand, Florida, United States | Suspended |
| Research Site | Doral, Florida, United States | Not Yet Recruiting |
| Research Site | Ocoee, Florida, United States | Recruiting |
| Research Site | Decatur, Georgia, United States | Not Yet Recruiting |
| Research Site | Potomac, Maryland, United States | Not Yet Recruiting |
| Research Site | Brooklyn, New York, United States | Suspended |
| Research Site | Cary, North Carolina, United States | Not Yet Recruiting |
| Research Site | Morehead City, North Carolina, United States | Not Yet Recruiting |
| Research Site | Myrtle Beach, South Carolina, United States | Not Yet Recruiting |
+ 120 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07664553